Status:

RECRUITING

PrePhage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants

Lead Sponsor:

Rigshospitalet, Denmark

Collaborating Sponsors:

Lise Aunsholt, Neonatologist, Clinical Professor

Conditions:

Necrotizing Enterocolitis

Microbial Substitution

Eligibility:

All Genders

Phase:

EARLY_PHASE1

Brief Summary

PrePhage - Fecal bacteriophage transfer for enhanced gastrointestinal tract maturation in preterm infants This pilot triol has the primary goal of demonstrating the safety of transferring viruses and...

Detailed Description

PrePhage - Fecal bacteriophage transfer for enhanced gastrointestinal tract maturation in preterm infants This pilot trial aims to investigate if fecal filtrate transfers (FFT) to preterm infants is ...

Eligibility Criteria

Inclusion

  • Inclusion criteria for participant preterm infants
  • Preterm infants born between GA 26+0 and 30+6
  • Delivery at RH or transferred to RH NICU within 24 hours of delivery
  • Children administered prophylactic antibiotics due to maternal risk factors, specifically: premature rupture of membranes, groub b streptococcus positive, feber during labour
  • Signed parental consent
  • Exclusion criteria for participant preterm infants
  • Major congenital anomalies or birth defects
  • Antibiotics for more than 72 hours after birthExtremely SGA infant (weight SD score \< -3 SD)
  • Need for mechanical ventilation or cardiovascular support before first FFT treatment
  • Inclusion criteria for mothers of participants
  • Women aged 18-45
  • Ability to give informed consent
  • Exclusion criteria for participant mothers
  • ● Mothers who have severe infection, defined by need for other treatment to support infection-related comorbidities, besides from antibiotics (e.g. inotropic treatment, iv fluid resuscitation)

Exclusion

    Key Trial Info

    Start Date :

    November 7 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2025

    Estimated Enrollment :

    20 Patients enrolled

    Trial Details

    Trial ID

    NCT05272579

    Start Date

    November 7 2023

    End Date

    December 31 2025

    Last Update

    November 15 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Rigshospitalet

    Copenhagen, Denmark, 2100